People at risk of colorectal cancer are sometimes prescribed daily aspirin. Scientists look into that preventative possibility and safety for everyone.
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...
TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
A resurfaced CIA document reveals that US intelligence once examined research hinting at a potential cancer treatment more than six decades ago.
Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candidate ...
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 win, with the Cereblon E3 ligase modulator (CELMoD) tied to a statistically significant improvement in progression-free survival (PFS) ...
�y!���0�����K#Du001a4�}��]�u0011ɷ�u000e�u0003��~u0019`� ...
Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to ...
Roche said the late-stage trial did not provide reliable evidence that the drug's use in combination with Pfizer's Ibrance ...
A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.
Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer improved survival in a late‑stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results